Price $186.29 |
Market Cap
129.71B
|
Sector Health Care |
Div. Growth
20.10%
|
|
P/E
16.3
|
P/B
4.14
|
P/S
5.69
|
Dividend %
2.60%
|
|
P/CF
-
|
P/FCF
21.7
|
Op. Cash Flow
10.47M
|
FCF
8.2
|
|
Op. Margin
44.70%
|
Net Margin
35.50%
|
ROE
26.60%
|
ROI
13.00%
|
|
ROA
10.40%
|
EPS Growth
12.20%
|
Current Ratio
4.1
|
Debt/Equity
101.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MGC Diagnostics Corp (MGCD) | $8.02 | - | - | 34.1M | Strong Buy |
| Community Health Systems (CYH) | $7.26 | - | - | 876.8M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $18.45 | - | - | 589.3M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $2.10 | - | - | 43.2M | Strong Buy |
| Champions Oncology Inc (CSBR) | $3.62 | - | - | 33.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
